Syncromune® Presents SYNC-T Therapy: Image-Guided Cryolysis and Intratumoral Immunotherapy at CIRSE 2026 Posted September 10, 2026
Syncromune® Presents Multi-Modal Efficacy Assessment Framework at Inaugural Gustave Roussy Intratumoral Immunotherapy Symposium Posted June 17, 2026
Syncromune®, Inc. Presents Innovative SYNC-T Combination Immunotherapy Approach at Major European Interventional Oncology Conference Posted April 29, 2026
Syncromune Continues to Strengthen Executive and Clinical Leadership with Appointment of Dr. Stephen P. Dale, M.D., as Chief Medical Officer Posted January 6, 2026
